Stephen advises clients on both contentious and non-contentious intellectual property matters including patents, trade marks, trade secrets and copyright. He represents and advises a broad range of clients in relation to the protection, exploitation and enforcement of their intellectual property rights.
He has significant experience representing those clients within the life sciences and technology fields having acted recently on some of the most significant licensing transactions in the life sciences industry. In connection with his life sciences practice Stephen also advises clients on UK and EU regulatory matters within that sector.
On trade marks Stephen advises leading brand owners on the exploitation, protection and enforcement of their trade mark portfolios.
On the contentious side, Stephen has been involved in a number of leading patent cases including representing Lonza Biologics in the Kirin-Amgen v. TKT litigation, the University of California in proceedings brought by Dendron and Boston Scientific in the Conor v. Angiotech litigation.
Stephen is an Honorary Teaching Fellow at the University of Manchester's school of Pharmacy and Pharmaceutical Studies. He is currently an examiner for one of the papers for CIPA (Patent Attorneys) and ITMA (Trade Mark Attorneys) students and has given many external lectures on topics including IP audits, licensing, research and development agreements and injunctions.
He has been listed as one of IAM's Top 250 Patent Licensing specialists since 2010.